Share on StockTwits

Research analysts at Westhouse Securities began coverage on shares of Advanced Oncotherapy PLC (LON:AVO) in a report released on Thursday, Stock Ratings reports. The firm set a “buy” rating and a GBX 9 ($0.15) price target on the stock. Westhouse Securities’ price objective suggests a potential upside of 182.57% from the stock’s previous close.

Advanced Oncotherapy PLC (LON:AVO) traded up 4.43% during mid-day trading on Thursday, hitting GBX 3.185. The stock had a trading volume of 1,381,102 shares. Advanced Oncotherapy PLC has a one year low of GBX 0.80 and a one year high of GBX 2.85. The stock’s 50-day moving average is GBX 3.29 and its 200-day moving average is GBX 3.09.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.